An In-Depth Look at the Faustman Lab Research – Part 2

Figure S2
Faustman holds that BCG vaccination's primary role in this case is to induce TNF-a expression, and that TNF-a's primary role in this case is to kill the defective autoreactive T cells after they have developed, implying that treatment with BCG will only work with patients who are already diabetic. Faustman put her theory to the test and treated three long-term diabetics with BCG to see whether it would have any effect on their disease status. Read more

TNF, BCG, and You and Me: An In-Depth Look at the Faustman Lab Research

And here’s where things get interesting for a cure-seeking diabetic: when scientists saw that cells were flooding islets with TNF-a, they decided to see what would happen if they changed the levels of TNF-a in mouse pancreases– and they found that changing the levels of TNF-a changes whether a mouse will get diabetes. Now take a guess: we have a blaring distress signal, TNF-a, that turns on all the cells of the adaptive immune system, and we have a... Read more

Omnipod Put to the Test

Omnipod Test 1
I have been extremely happy with the Omnipod and require less insulin than I used to because I never detach. I feel that my work outs are better now and I am more comfortable in my daily routine. In April of this year, I decided sign up for run my first “Mudder” race called the Rugged Maniac. The Rugged Maniac is a 5K mud run full of military-style obstacles, designed by British Special Forces. Read more

Faustman Lab Research: How Excited Should You Be?

Vial and Syringe copy
Last week, diabetes headlines were dominated by a new study from the Faustman Lab at Massachusetts General Hospital, published on Wednesday, August 8th on PLoS One, suggesting that a 90-year-old tuberculosis vaccine called BCG might hold promise for people living with type 1 diabetes. “Human Study Reignites Debate Over Controversial Diabetes ‘Cure,’” wrote Reuters. “Diabetes May Be Reversed By Long-Used Vaccine for TB,” proclaimed Bloomberg news. Read more

Fundraiser for a Type 1 Diabetic Refugee from South Sudan

Samuel - 1 copy
When Dr. Mariela Glandt, an endocrinologist, volunteered to treat African refugees in Tel Aviv, she had no idea she would meet a type 1 diabetic like Samuel Agant, 28, from South Sudan. Below, Dr. Glandt shares Samuel’s story of living on the streets of Tel Aviv with type 1 diabetes, without a work permit, without food, and without a constant supply of insulin. Read more

Medtronic’s Enlite Sensor: The Waiting is the Hardest Part

Medtronic Enlite CGM Sensor1
First, the new Enlite sensor — and I really should use “new” in quotation marks because it has been available in Europe for about a year — is much more comfortable and accurate than previous Minimed sensors. Second, the Veo pump itself has a glucose suspend feature, meaning that if the Enlite sensor detects your blood glucose is below 70, it can stop insulin delivery on its own. Read more

Subscribe to our Newsletter

Hide me